Modulation of the connexin26 tumor suppressor gene expression through methylation in human mammary epithelial cell lines

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 59-64

  Singal, R ^a   Tu, Z J ^b   Vanwert, J M ^a   Ginder, G D ^c   Kiang, D T ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Breast cancer; Connexin 26 gene; DNA methylation; Gene expression

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CONNEXIN 26; DNA METHYLTRANSFERASE; METHYLTRANSFERASE INHIBITOR;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BREAST; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CONNEXINS; DNA; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED;

EID: 0034113011     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Loewenstein WR: Junctional intercellular communication and the control of growth. Biochim Biophys Acta 560: 1-65, 1979.
2. Fraser SE, Green CR, Bode HR, and Gilula NB: Selective disruption of gap junctional communication interferes with a patterning process in hydra. Science 237: 49-55, 1987.
3. Beyer EC, Paul DL, and Goodenough DA: Connexin family of gap junction proteins. J Membr Biol 116: 187-94, 1990.
4. Pozzi A, Risek B, Kiang DT, Gilula NB, and Kumar NM: Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp Cell Res 220: 212-9, 1995.
5. Lee SW, Tomasetto C, and Sager R: Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88: 2825-9, 1991.
6. Kiang DT, Jin N, and Lin HH: Gene expression of gap junction proteins in benign and malignant human breast tissues. In: Proceedings of the American Association For Cancer Research 1994 pp. 276.
7. Mesnil M, Krutovskikh V, Piccoli C, Elfgang C, Traub O, Willecke K, and Yamasaki H: Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res 55: 629-39, 1995.
8. Hirschi KK, Xu CE, Tsukamoto T, and Sager R: Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 7: 861-70, 1996.
9. Duflot-Dancer A, Mesnil M, and Yamasaki H: Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 15: 2151-8, 1997.
10. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, and Sidransky D: 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers [see comments]. Nature Medicine 1: 686-92, 1995.
11. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, and Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-30, 1995.
12. Zhu WB, Mironov N, and Yamasaki H: Hypermethylation of connexin32 gene as a mechanism of disruption of cell-cell communication in tumors. In: Proceedings of the American Association for Cancer Research 1998, pp. 199.
13. Piechocki MP, Burk RD, and Ruch RJ: Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells [In Process Citation]. Carcinogenesis 20: 401-6, 1999.
14. Kiang DT, Jin N, Tu ZJ, and Lin HH: Upstream genomic sequence of the human connexin 26 gene. Gene 199: 165-71, 1997.
15. Singal R, Ferris R, Little JA, Wang SZ, and Ginder GD: Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells. Proc Natl Acad Sci USA 94: 13724-9, 1997.
16. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-9, 1987.
17. el-Fouly MH, Trosko JE, and Chang CC: Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 168: 422-30, 1987.
18. Herman JG, Graff JR, Myohanen S, Nelkin BD, and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-6, 1996.
19. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, and Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89: 1827-31, 1992.
20. Xiong Z and Laird PW: COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 25: 2532-4, 1997.
21. Taylor SM and Jones PA: Mechanism of action of eukaryotic DNA methyltransferase. Use of 5-azacytosine-containing DNA. J Mol Biol 162: 679-92, 1982.
22. Friedman S: The irreversible binding of azacytosine-containing DNA fragments to bacterial DNA(cytosine-5)methyltransferases. J Biol Chem 260: 5698-705, 1985.
23. Singal R and Ginder GD: DNA methylation. Blood 93: 4059-70, 1999.
24. Baylin SB, Herman JG, Graff JR, Vertino PM, and Issa JP: Alterations in DNA methylation: a fundamental aspect of neoplasia. [Review] [248 refs]. Advances in Cancer Res 72: 141-96, 1998.
25. Jones PA: The DNA methylation paradox. Trends Genet 15: 34-7, 1999.
26. Antequera F, Boyes J, and Bird A: High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62: 503-14, 1990.
27. Jones PA, Wolkowicz MJ, Rideout WMd, Gonzales FA, Marziasz CM, Coetzee GA, and Tapscott SJ: De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87: 6117-21, 1990.